How can artificial intelligence and machine learning be used to gather and process real-time manufacturing data?
New technologies, such as artificial intelligence and machine learning, are being employed by bio/pharma manufacturers to collect and analyze large amounts of process data in real-time. Hear an expert panel will discuss how this technology can be employed to optimize bio/pharma manufacturing and predictive maintenance.
This Editors’ Series panel discussion, moderated by the editors of Pharmaceutical Technology and BioPharm International, features Bikash Chatterjee, CEO, Pharmatech Associates; Pamela Docherty, life sciences industry manager, Siemens; Amos Dor, general manager of the Pharma team, automation products group, Applied Materials; and Bob Lenich, global life sciences director, Emerson.
The panel discussion—Technology Advances in Process Operations: Using Real-time Montioring and Artificial Intelligence to Optimize Manufacturing Operations was recorded during the 2020 Bio/Pharma Virtual Congress on Nov. 11, 2020.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.